MedPath

GILEAD SCIENCES HONG KONG LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

19

PPB:19

Drug Approvals

SUNLENCA SOLUTION FOR INJECTION 463.5MG/1.5ML

Approval Date
Feb 26, 2024
PPB

SUNLENCA TABLETS 300MG

Approval Date
Feb 26, 2024
PPB

TRODELVY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 180MG

Approval Date
Oct 21, 2022
PPB

♇ VEKLURY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG

Approval Date
Jul 17, 2020
PPB

BIKTARVY TABLETS

Approval Date
Sep 26, 2018
PPB

VOSEVI TABLETS

Approval Date
Jun 19, 2018
PPB

VEMLIDY TABLETS 25MG

Approval Date
Jul 27, 2017
PPB

EPCLUSA TABLETS 400MG/100MG

Approval Date
Mar 15, 2017
PPB

DESCOVY TABLETS 200MG/10MG

Approval Date
Oct 3, 2016
PPB

DESCOVY TABLETS 200MG/25MG

Approval Date
Oct 3, 2016
PPB
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.